Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2023-03-20 00:00:00 ET · period of report 2023-01-15 · accession 0001415889-23-005235 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-20 | 2023-03-16+ | KNSA | Moat Ross | Chief COMMERCIAL Off | M - OptEx | — | +3,131 | 11.0K | +40% | — |
| DM | 2023-03-20 | 2023-03-16+ | KNSA | Moat Ross | Chief COMMERCIAL Off | F - Tax | $11.23 | -1,710 | 11.4K | -13% | -$19.2K |
| D | 2023-03-20 | 2023-01-15 | KNSA | Moat Ross | Chief COMMERCIAL Off | A - Grant | $9.56 | +1,844 | 10.0K | +23% | +$17.6K |
| DM | 2023-03-20 | 2023-03-16+ | KNSA | Moat Ross | Chief COMMERCIAL Off | M - OptEx | $0.00 | -3,131 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2023-03-20 | M | A | 2,137 | — | 12,596 | D | — | — | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 2 | Common | Class A Common Share | 2023-03-16 | F | D | 543 | $11.46 | 10,459 | D | — | — | |
| 3 | Common | Class A Common Share | 2023-03-16 | M | A | 994 | — | 11,002 | D | — | — | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 4 | Common | Class A Common Share | 2023-01-15 | A | A | 1,844 | $9.56 | 10,008 | D | — | — | |
| 5 | Common | Class A Common Share | 2023-03-20 | F | D | 1,167 | $11.12 | 11,429 | D | — | — | |
| 6 | Derivative | Restricted Share Unit | 2023-03-16 | M | D | 994 | $0.00 | 1,988 | D | — · — to — | 994 Class A Common Share | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F3) The RSUs vest over a four year period, with 25% of the RSUs vesting on each anniversary of the date of grant, March 16, 2021. |
| 7 | Derivative | Restricted Share Unit | 2023-03-20 | M | D | 2,137 | $0.00 | 0 | D | — · — to — | 2,137 Class A Common Share | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F4) The performance criteria for these RSUs were met. The RSUs vested in a single installment on March 20, 2023; there was no expiration date for the RSUs. |